There is a lack of accurate knowledge about the effects of PDT on some molecules that are important for the effectiveness of glioma therapy, such as transforming growth factor β (TGF-β), and the information on some of them (e.g., HGF, HDACs, GFAP, and others) is far from sufficient. The gene discussed is TGFB1; the disease is central nervous system cancer.